See analyst estimates and all valuation multiples for Biopharmaceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $793B | 13.4x | 31.2x | |
| $483B | 5.2x | 13.8x | |
| $467B | 7.8x | 18.2x | |
| $291B | 3.7x | 9.5x | |
| $287B | 4.9x | 14.0x | |
| $261B | 4.7x | 11.4x | |
| $242B | 3.8x | 8.3x | |
| $236B | 4.9x | 10.1x | |
| $205B | 5.8x | 11.3x | |
| $186B | 3.0x | 7.6x | |
| $167B | 5.8x | 11.1x | |
| $133B | 2.5x | 8.5x | |
| $127B | 2.7x | 7.9x | |
| $114B | 2.6x | 7.8x | |
| $103B | 8.7x | 22.2x | |
| $71.6B | 2.4x | 8.9x | |
| $69.6B | 1.3x | 6.2x | |
| $69.2B | 7.3x | 16.9x | |
| $68.4B | 8.4x | 16.5x | |
| $67.4B | 2.7x | 9.5x | |
| $65.9B | 4.2x | 12.5x | |
| $54.0B | 5.8x | 19.7x | |
| $53.2B | 11.6x | 39.6x | |
| $53.0B | 11.6x | 39.5x | |
| $44.6B | 3.4x | 15.8x | |
| $43.7B | 7.0x | 24.6x | |
| $38.0B | 2.2x | 7.8x | |
| $33.0B | 2.9x | 13.9x | |
| $28.9B | 10.0x | 28.9x | |
| $27.5B | 1.7x | 7.2x | |
| $25.9B | 1.8x | 6.2x | |
| $24.6B | 2.5x | 7.7x | |
| $23.2B | 1.8x | 8.4x | |
| $22.5B | 7.7x | 8.1x | |
| $22.4B | 11.2x | 30.0x | |
| $22.3B | 2.2x | 6.5x | |
| $19.2B | 49.5x | 464.8x | |
| $17.6B | 2.0x | 8.3x | |
| $17.5B | 115.5x | 208.6x | |
| $16.9B | 9.5x | 76.3x | |
| $14.9B | 4.1x | 11.1x | |
| $14.7B | 3.2x | 12.2x | |
| $14.6B | 4.8x | 12.9x | |
| $14.1B | 10.1x | 30.7x | |
| $13.3B | 4.5x | 11.9x | |
| $13.3B | 2.3x | 13.2x | |
| $13.1B | 4.7x | 19.5x | |
| $13.0B | 4.0x | 16.1x | |
| $12.8B | 28.5x | -853.4x | |
| $12.2B | 7.8x | 30.8x | |
| $12.2B | 2.1x | 14.6x | |
| $12.0B | 43.9x | -272.7x | |
| $11.9B | 0.3x | 5.4x | |
| $11.6B | 14.5x | 46.2x | |
| $11.4B | n/a | n/a | |
| $11.2B | 3.0x | 11.8x | |
| $11.1B | 2.6x | 6.9x | |
| $10.8B | 3.9x | 13.7x | |
| $10.4B | 3.8x | 15.4x | |
| $10.3B | 3.3x | 8.2x | |
| $10.3B | 3.1x | 7.6x | |
| $10.2B | 4.8x | 13.0x | |
| $10.0B | 1.6x | 5.1x | |
| $9.7B | 2.4x | 8.8x | |
| $9.7B | 1.6x | 12.4x | |
| $8.7B | n/a | n/a | |
| $8.5B | 6.7x | 10.4x | |
| $8.5B | n/a | n/a | |
| $8.2B | 1.6x | 12.4x | |
| $7.8B | 3.3x | 5.6x | |
| $7.6B | 744.7x | -36.2x | |
| $7.3B | 2.0x | 9.5x | |
| $7.2B | 3.9x | 18.5x | |
| $7.2B | 4.6x | 23.4x | |
| $6.9B | 18.2x | -363.2x | |
| $6.8B | 8.9x | 33.1x | |
| $6.8B | 2.0x | 7.7x | |
| $6.5B | 2.0x | 9.0x | |
| $6.5B | 2.8x | 8.7x | |
| $6.4B | 5.6x | 18.8x | |
| $6.3B | 16.5x | 24.5x | |
| $6.3B | 1.5x | 8.2x | |
| $6.2B | n/a | n/a | |
| $6.1B | 3.7x | 19.9x | |
| $6.1B | 4.0x | 49.5x | |
| $6.0B | 3.1x | 12.2x | |
| $5.7B | 1.9x | 8.4x | |
| $5.5B | 9.7x | 29.6x | |
| $5.5B | 1.7x | 7.3x | |
| $5.4B | n/a | n/a | |
| $5.4B | 6.4x | 22.5x | |
| $5.3B | 1.9x | 5.2x | |
| $5.3B | 11.2x | 35.6x | |
| $5.0B | 6.0x | 27.2x | |
| $5.0B | 14.4x | -60.2x | |
| $4.9B | 5.2x | 13.6x | |
| $4.8B | 10.7x | 33.6x | |
| $4.7B | 2660.0x | -16.9x | |
| $4.2B | n/a | n/a | |
| $4.2B | 3.0x | 10.9x | |
| $4.1B | 1.6x | 9.1x | |
| $4.0B | 2.7x | 10.5x | |
| $4.0B | 7.9x | 21.1x | |
| $3.8B | 4.4x | 16.0x | |
| $3.7B | 2.2x | 10.8x | |
| $3.7B | 11.6x | 73.3x | |
| $3.7B | 3.4x | 15.9x | |
| $3.6B | 7.4x | 16.6x | |
| $3.6B | 106.3x | n/a | |
| $3.6B | 5.2x | 18.9x | |
| $3.6B | 5.6x | 16.0x | |
| $3.5B | 5.3x | 14.5x | |
| $3.5B | n/a | n/a | |
| $3.4B | 1.6x | 10.8x | |
| $3.3B | 4.8x | n/a | |
| $3.3B | n/a | n/a | |
| $3.3B | n/a | -21.2x | |
| $3.2B | 2.6x | 12.3x | |
| $3.2B | 28.6x | -605.4x | |
| $3.1B | 33.9x | -29.1x | |
| $3.1B | 57.3x | -1692.0x | |
| $3.0B | 2.2x | 8.1x | |
| $3.0B | 9.0x | -129.6x | |
| $2.9B | 4.3x | 12.8x | |
| $2.9B | n/a | -14.7x | |
| $2.9B | 7.2x | 21.5x | |
| $2.7B | 7.1x | -28.3x | |
| $2.7B | 4.3x | 10.3x | |
| $2.7B | 3.8x | 19.8x | |
| $2.7B | 13.2x | -56.9x | |
| $2.6B | 6.7x | -34.7x | |
| $2.6B | 2468.2x | -7.1x | |
| $2.6B | n/a | -11.9x | |
| $2.6B | 15.5x | 26.0x | |
| $2.6B | n/a | n/a | |
| $2.5B | 21.8x | -93.3x | |
| $2.5B | 13.0x | 38.0x | |
| $2.5B | 3.1x | 11.7x | |
| $2.5B | 3.9x | 30.7x | |
| $2.4B | 2.9x | 14.3x | |
| $2.3B | 15.5x | n/a | |
| $2.2B | 2.9x | 18.0x | |
| $2.2B | 6.0x | 16.7x | |
| $2.2B | 3.7x | 16.8x | |
| $2.2B | n/a | -8.8x | |
| $2.2B | 6.9x | 17.5x | |
| $2.1B | 9.7x | -60.6x | |
| $2.1B | 5.3x | 14.7x | |
| $1.8B | 6.5x | 44.3x | |
| $1.8B | 6.9x | 58.4x | |
| $1.7B | 2.4x | 4.0x | |
| $1.7B | 23375.1x | -8.2x | |
| $1.7B | 11.3x | 27.6x | |
| $1.7B | 3.8x | 14.9x | |
| $1.7B | n/a | -4.7x | |
| $1.7B | 3.9x | n/a | |
| $1.7B | 5.6x | 10.7x | |
| $1.7B | n/a | n/a | |
| $1.6B | 26.0x | 52.7x | |
| $1.6B | 2.5x | 11.0x | |
| $1.6B | n/a | n/a | |
| $1.6B | 0.7x | 4.1x | |
| $1.6B | 2.2x | 6.0x | |
| $1.6B | 5.9x | 23.2x | |
| $1.6B | n/a | n/a | |
| $1.5B | 16.6x | n/a | |
| $1.5B | 9.3x | -343.8x | |
| $1.5B | 7.7x | 25.3x | |
| $1.4B | n/a | n/a | |
| $1.4B | n/a | -16.9x | |
| $1.4B | 6.3x | 26.3x | |
| $1.4B | n/a | n/a | |
| $1.4B | 5.2x | n/a | |
| $1.4B | 48.6x | -11.9x | |
| $1.3B | 5.6x | -3.6x | |
| $1.3B | 53.5x | -12.4x | |
| $1.3B | 0.6x | 6.3x | |
| $1.3B | n/a | -6.1x | |
| $1.3B | 2.7x | 15.2x | |
| $1.3B | 1.2x | 5.2x | |
| $1.2B | 2.1x | -94.7x | |
| $1.2B | 11.0x | 39.1x | |
| $1.2B | 8.0x | 23.6x | |
| $1.2B | 42.7x | n/a | |
| $1.2B | 11.1x | 303.5x | |
| $1.2B | n/a | -6.5x | |
| $1.2B | 9.3x | -23.6x | |
| $1.2B | 3.1x | -76.5x | |
| $1.2B | 3.0x | 13.7x | |
| $1.1B | 31.3x | -5.9x | |
| $1.1B | 19.4x | -6.4x | |
| $1.1B | 1.8x | -8.1x | |
| $1.1B | 1.3x | 5.5x | |
| $1.1B | n/a | n/a | |
| $1.1B | 364.4x | n/a | |
| $1.1B | 2.9x | n/a | |
| $1.0B | 2.8x | 3.2x | |
| $1.0B | n/a | -6.9x | |
| $1.0B | 6.5x | -6.3x | |
| $998M | 410.5x | -6.9x | |
| $997M | n/a | n/a | |
| $994M | n/a | n/a | |
| $991M | n/a | -8.2x | |
| $940M | n/a | n/a | |
| $930M | 156317.8x | -7.8x | |
| $918M | 2.7x | 44.4x | |
| $909M | 16.1x | n/a | |
| $902M | n/a | n/a | |
| $891M | 2.7x | 65.8x | |
| $877M | n/a | -6.1x | |
| $874M | 2.4x | -3109.7x | |
| $851M | 868.1x | -8.7x | |
| $848M | 7.4x | -7.3x | |
| $837M | 1.4x | 6.8x | |
| $831M | 7.1x | 26.3x | |
| $831M | 63.8x | n/a | |
| $750M | n/a | -7.4x | |
| $749M | 2.6x | 6.2x | |
| $746M | n/a | n/a | |
| $742M | 7.1x | 26.0x | |
| $740M | n/a | n/a | |
| $722M | n/a | n/a | |
| $713M | 66.4x | -9.6x | |
| $711M | 15.6x | 126.5x | |
| $686M | 4.7x | -2.4x | |
| $678M | 1.6x | 7.5x | |
| $675M | 2.5x | 11.2x | |
| $655M | 8.8x | -8.1x | |
| $643M | 51.7x | -2.0x | |
| $639M | n/a | n/a | |
| $637M | 1.1x | 8.8x | |
| $631M | 4.8x | -3.5x | |
| $626M | n/a | n/a | |
| $588M | 31.1x | n/a | |
| $588M | 29.5x | -183.8x | |
| $584M | 3.4x | 17.3x | |
| $554M | n/a | n/a | |
| $547M | 48.0x | -3.6x | |
| $545M | n/a | -4.3x | |
| $536M | 52.5x | -4.1x | |
| $519M | n/a | n/a | |
| $515M | 186.9x | -26.2x | |
| $514M | n/a | n/a | |
| $513M | n/a | -3.8x | |
| $506M | 20398.2x | n/a | |
| $484M | 5.0x | 13.9x | |
| $472M | 2.1x | n/a | |
| $463M | 1.4x | 5.3x | |
| $463M | n/a | -3.4x | |
| $447M | n/a | -3.0x | |
| $441M | 6.7x | -18.7x | |
| $437M | 2.4x | 10.0x | |
| $420M | 29.8x | 56.9x | |
| $413M | 3.7x | 8.7x | |
| $406M | 1.1x | 8.0x | |
| $405M | 10.6x | -4.1x | |
| $404M | 1.4x | 10.2x | |
| $402M | 2.0x | -4.6x | |
| $401M | 3.3x | 67.0x | |
| $400M | n/a | -3.6x | |
| $398M | 6.5x | 26.0x | |
| $361M | 13.8x | -7.4x | |
| $351M | 24.7x | -8.1x | |
| $342M | 1.9x | 8.1x | |
| $337M | 0.8x | 7.2x | |
| $330M | 16.7x | -1124.2x | |
| $320M | n/a | n/a | |
| $319M | 58.6x | -8.7x | |
| $319M | 4.6x | 25.3x | |
| $308M | n/a | n/a | |
| $291M | n/a | n/a | |
| $281M | n/a | n/a | |
| $276M | 6.9x | -30.3x | |
| $271M | 1.9x | -1.7x | |
| $259M | 78.4x | -1.1x | |
| $252M | n/a | n/a | |
| $245M | n/a | -1.6x | |
| $245M | 10.6x | -107.2x | |
| $245M | n/a | -32.3x | |
| $239M | 5.3x | 17.2x | |
| $229M | 4.9x | 20.8x | |
| $229M | 28.5x | -7.2x | |
| $227M | n/a | n/a | |
| $221M | 3.5x | 7.6x | |
| $219M | n/a | n/a | |
| $211M | 1366.9x | n/a | |
| $209M | 7.4x | n/a | |
| $204M | n/a | n/a | |
| $202M | 5.1x | n/a | |
| $198M | 2.4x | -8.4x | |
| $197M | n/a | n/a | |
| $195M | 8.7x | -4.5x | |
| $194M | 1.6x | 16.7x | |
| $193M | n/a | n/a | |
| $191M | 18899.7x | -2.0x | |
| $189M | 52.6x | -4.3x | |
| $188M | 2.8x | n/a | |
| $186M | 92.1x | -6.0x | |
| $184M | 33.0x | -14.2x | |
| $183M | 37.1x | -0.8x | |
| $175M | n/a | -12.5x | |
| $173M | n/a | n/a | |
| $158M | 13.0x | -7.4x | |
| $152M | 2.6x | n/a | |
| $152M | 12.3x | -3.6x | |
| $147M | 8.3x | -3.0x | |
| $146M | 2.6x | 98.1x | |
| $145M | 8.7x | -3.3x | |
| $140M | 34.0x | -10.0x | |
| $136M | n/a | n/a | |
| $135M | 381.5x | n/a | |
| $131M | 33.1x | -0.9x | |
| $126M | 107.7x | -26.5x | |
| $126M | 35.3x | -1.7x | |
| $126M | n/a | n/a | |
| $121M | n/a | -0.6x | |
| $121M | n/a | n/a | |
| $119M | n/a | n/a | |
| $113M | n/a | -8.5x | |
| $113M | n/a | -1.2x | |
| $112M | 1.6x | 10.1x | |
| $112M | n/a | n/a | |
| $107M | n/a | n/a | |
| $103M | 6.7x | 23.2x | |
| $96.9M | n/a | n/a | |
| $96.8M | n/a | n/a | |
| $96.5M | 1.2x | -3.4x | |
| $96.5M | n/a | n/a | |
| $91.2M | 0.9x | -1.3x | |
| $85.5M | n/a | n/a | |
| $85.3M | n/a | -1.7x | |
| $83.6M | 7.9x | -49.2x | |
| $81.2M | 9.9x | -2.7x | |
| $77.8M | 3.1x | 12.4x | |
| $77.3M | 18.2x | -5.7x | |
| $73.6M | 1206.4x | n/a | |
| $69.6M | n/a | n/a | |
| $68.6M | n/a | n/a | |
| $68.1M | 2.3x | -0.9x | |
| $64.6M | n/a | n/a | |
| $63.0M | n/a | n/a | |
| $61.1M | 0.3x | -1.1x | |
| $61.0M | n/a | n/a | |
| $59.6M | 7.1x | -7.9x | |
| $58.8M | n/a | n/a | |
| $55.9M | n/a | n/a | |
| $55.8M | 6.0x | 3.0x | |
| $55.1M | n/a | n/a | |
| $51.6M | 27.0x | -145.0x | |
| $50.9M | n/a | n/a | |
| $50.8M | n/a | n/a | |
| $50.3M | 19.8x | -1.0x | |
| $47.1M | n/a | n/a | |
| $45.8M | 9.5x | n/a | |
| $43.6M | n/a | -2.3x | |
| $43.2M | 1.7x | 11.8x | |
| $42.9M | 38.9x | -4.5x | |
| $42.7M | 6.3x | n/a | |
| $41.9M | 11.0x | n/a | |
| $41.3M | n/a | n/a | |
| $41.2M | 44.5x | -4.3x | |
| $40.2M | 10.5x | n/a | |
| $37.6M | n/a | n/a | |
| $37.4M | 1.8x | -0.2x | |
| $36.5M | n/a | n/a | |
| $36.2M | 4.8x | 302.0x | |
| $35.5M | 67.0x | -2.9x | |
| $34.8M | 1.9x | 43.2x | |
| $33.9M | n/a | n/a | |
| $33.6M | n/a | n/a | |
| $32.5M | n/a | n/a | |
| $29.9M | 29.8x | -7.9x | |
| $29.6M | n/a | n/a | |
| $27.9M | n/a | n/a | |
| $27.1M | n/a | -15.1x | |
| $27.0M | n/a | n/a | |
| $26.5M | n/a | n/a | |
| $25.2M | n/a | -6.2x | |
| $24.1M | 7.7x | -5.8x | |
| $23.7M | n/a | n/a | |
| $23.7M | n/a | -5.0x | |
| $23.5M | 12.1x | -771.7x | |
| $21.8M | n/a | n/a | |
| $21.5M | n/a | n/a | |
| $20.1M | n/a | n/a | |
| $19.6M | 2.8x | -1.0x | |
| $19.6M | 2.9x | 8.1x | |
| $19.6M | n/a | n/a | |
| $19.3M | n/a | n/a | |
| $19.2M | n/a | n/a | |
| $17.1M | n/a | n/a | |
| $16.5M | n/a | n/a | |
| $16.0M | 5.1x | -2.0x | |
| $15.4M | n/a | -3.9x | |
| $15.3M | n/a | n/a | |
| $15.2M | n/a | n/a | |
| $15.0M | n/a | n/a | |
| $14.9M | n/a | n/a | |
| $14.9M | n/a | n/a | |
| $14.7M | n/a | n/a | |
| $14.7M | 3.4x | -3.2x | |
| $14.2M | 10.2x | -34.6x | |
| $14.1M | n/a | -3.0x | |
| $13.6M | n/a | n/a | |
| $13.1M | 0.7x | -4.8x | |
| $12.7M | n/a | n/a | |
| $12.6M | 11.9x | -5.2x | |
| $12.4M | 4.0x | -4.3x | |
| $12.4M | n/a | n/a | |
| $12.1M | 0.2x | -0.1x | |
| $11.9M | 73.0x | -5.4x | |
| $11.8M | n/a | n/a | |
| $11.0M | n/a | n/a | |
| $10.9M | 6.5x | -0.3x | |
| $10.7M | n/a | n/a | |
| $10.5M | n/a | n/a | |
| $10.0M | n/a | -5.0x | |
| $9.7M | 5.3x | -0.7x | |
| $9.5M | n/a | n/a | |
| $9.5M | n/a | n/a | |
| $8.7M | 6.3x | -2.0x | |
| $8.7M | 9.7x | -10.4x | |
| $8.7M | n/a | n/a | |
| $7.7M | 6.3x | -0.6x | |
| $7.2M | n/a | -10.8x | |
| $7.0M | n/a | -1.2x | |
| $6.8M | n/a | n/a | |
| $6.7M | n/a | -7.3x | |
| $6.3M | n/a | n/a | |
| $6.2M | 12.3x | n/a | |
| $5.5M | 0.7x | -3.5x | |
| $5.2M | n/a | n/a | |
| $5.2M | n/a | n/a | |
| $5.1M | 41.4x | -1.6x | |
| $4.7M | n/a | n/a | |
| $4.7M | n/a | n/a | |
| $4.6M | 23.3x | -1.4x | |
| $4.5M | n/a | -1.3x | |
| $4.5M | n/a | n/a | |
| $4.1M | n/a | -2.4x | |
| $3.7M | n/a | n/a | |
| $3.7M | n/a | n/a | |
| $3.7M | n/a | n/a | |
| $3.3M | n/a | n/a | |
| $3.1M | n/a | n/a | |
| $2.5M | n/a | n/a | |
| $2.3M | n/a | n/a | |
| $2.2M | n/a | n/a | |
| $2.0M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.5M | n/a | n/a | |
| $1.4M | 1.7x | n/a | |
| $1.4M | n/a | 0.3x | |
| $1.1M | n/a | n/a | |
| $1.0M | 2.5x | -0.1x | |
| $0.9M | n/a | n/a | |
| $0.8M | n/a | n/a | |
| $0.8M | 0.5x | -0.0x | |
| $0.5M | n/a | n/a | |
| $0.5M | n/a | n/a | |
| $0.3M | n/a | n/a | |
| $0.2M | n/a | n/a | |
| $0.1M | 0.0x | -0.0x | |
| -$0.2M | n/a | n/a | |
| -$0.2M | n/a | n/a | |
| -$0.3M | n/a | n/a | |
| -$0.4M | n/a | n/a | |
| -$1.9M | -2.4x | 0.2x | |
| -$2.5M | n/a | n/a | |
| -$5.7M | n/a | n/a | |
| -$6.5M | n/a | 0.8x | |
| -$11.4M | -2.7x | 0.1x | |
| -$21.6M | -8.6x | n/a | |
| -$102M | -42.9x | 0.5x | |
| -$112M | -3.6x | 0.7x | |
| -$1.5B | -4.7x | 7.4x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Biopharmaceuticals